Full Text of SB1882 103rd General Assembly
SB1882enr 103RD GENERAL ASSEMBLY |
| | SB1882 Enrolled | | LRB103 27260 RLC 53631 b |
|
| 1 | | AN ACT concerning animals.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 1. Short title. This Act may be cited as the | 5 | | Protection of Dogs and Cats from Unnecessary Testing Act. | 6 | | Section 5. Definitions. In this Act: | 7 | | "Alternative test method" means a test method that does | 8 | | not use animals, or in some cases reduces or refines the use of | 9 | | animals, for which the reliability and relevance for a | 10 | | specific purpose has been established by validation bodies, | 11 | | including, but not limited to, the Inter-Agency Coordinating | 12 | | Committee for the Validation of Alternative Methods and the | 13 | | Organisation for Economic Co-operation and Development. | 14 | | Alternative test methods include, but are not limited to, | 15 | | high-throughput screening methods, testing of categories of | 16 | | chemical substances, tiered testing methods, in vitro studies, | 17 | | and systems biology.
| 18 | | "Cat" means a small domesticated carnivorous mammal that | 19 | | is a member of the family Felidae, order Carnivora.
| 20 | | "Canine or feline toxicological experiment" means any test | 21 | | or study of any duration that seeks to determine the effect, if | 22 | | any, of the application or exposure, whether internal or | 23 | | external, of any amount of a chemical substance on a dog or |
| | | SB1882 Enrolled | - 2 - | LRB103 27260 RLC 53631 b |
|
| 1 | | cat. "Application or exposure" includes, but is not limited | 2 | | to, oral ingestion, skin or eye contact, or inhalation. | 3 | | "Application or exposure" does not include testing of | 4 | | veterinary products for canine or feline health.
| 5 | | "Chemical substance" means any organic or inorganic | 6 | | substance, including, but not limited to, a drug, as defined | 7 | | in Section 321(g) of Title 21 of the United States Code, a | 8 | | pesticide, as defined in Section 136(u) of Title 7 of the | 9 | | United States Code, a chemical substance, as defined in | 10 | | Section 2602(2) of Title 15 of the United States Code, or a | 11 | | food additive, as defined in Section 321(s) of Title 21 of the | 12 | | United States Code.
| 13 | | "Testing facility" means any partnership, corporation, | 14 | | association, school, institution, organization, or other legal | 15 | | relationship, whether privately or government owned, leased, | 16 | | or operated, that tests chemicals, ingredients, product | 17 | | formulations, or products in this State.
| 18 | | "Dog" means any member of the species Canis familiaris.
| 19 | | "Medical research" means research related to the causes, | 20 | | progression, diagnosis, treatment, control, or prevention of | 21 | | physical or mental diseases and impairments or chronic | 22 | | conditions of humans or animals or related to the development | 23 | | of biomedical products or devices, as defined under Section | 24 | | 321(h) of Title 21 of the United States Code. Medical research | 25 | | does not include research related to the development of drugs | 26 | | as defined in Section 321(g)(1) of Title 21 of the United |
| | | SB1882 Enrolled | - 3 - | LRB103 27260 RLC 53631 b |
|
| 1 | | States Code.
| 2 | | Section 10. Prohibition on the use of dogs or cats in | 3 | | toxicological experiments; exemptions; enforcement.
| 4 | | (a) Notwithstanding any law to the contrary, and in | 5 | | addition to the prohibitions set forth in law, a testing | 6 | | facility shall not conduct a canine or feline toxicological | 7 | | experiment in this State unless the experiment is conducted | 8 | | for any of the following purposes:
| 9 | | (1) Medical research.
| 10 | | (2) To comply with federal requirements pertaining to | 11 | | the approval or maintenance of a medical device, as | 12 | | defined under Section 321(h) of Title 21 of the United | 13 | | States Code.
| 14 | | (3) To achieve discovery, approval, or maintenance of | 15 | | a drug, pursuant to a testing requirement imposed by the | 16 | | United States Food and Drug Administration under Section | 17 | | 505 or 512 of the Federal Food, Drug, and Cosmetic Act or | 18 | | Section 351 of the Public Health Service Act or any | 19 | | binding agency regulation promulgated upon notice and | 20 | | comment thereunder, if the United States Food and Drug | 21 | | Administration has not otherwise expressly authorized drug | 22 | | manufacturers to use alternative test methods.
| 23 | | (4) To achieve discovery, approval, or maintenance of | 24 | | a biologic, pursuant to a testing requirement imposed by | 25 | | the United States Department of Agriculture under the |
| | | SB1882 Enrolled | - 4 - | LRB103 27260 RLC 53631 b |
|
| 1 | | Virus-Serum-Toxin Act or any binding agency regulation | 2 | | promulgated upon notice and comment thereunder, if the | 3 | | United States Department of Agriculture has not concluded | 4 | | that waivers shall be granted for the experimentation or | 5 | | studies or expressly indicated acceptance of alternative | 6 | | test methods.
| 7 | | (5) To achieve discovery, approval, registration, or | 8 | | maintenance of a pesticide, pursuant to a testing | 9 | | requirement imposed by the United States Environmental | 10 | | Protection Agency pursuant to the Federal Insecticide, | 11 | | Fungicide, and Rodenticide Act, or any binding agency | 12 | | regulation promulgated upon notice and comment thereunder, | 13 | | if the Environmental Protection Agency has not concluded | 14 | | that waivers shall be granted for such experimentation or | 15 | | studies or expressly indicated acceptance of alternative | 16 | | test methods.
| 17 | | (6) To comply with a requirement to conduct the | 18 | | experiment under the Toxic Substances Control Act, if the | 19 | | United States Environmental Protection Agency has not, | 20 | | pursuant to Section 2603(h) of Title 15 of the United | 21 | | States Code, concluded that waivers shall be granted for | 22 | | such experimentation or studies or expressly indicated | 23 | | acceptance of testing methods alternative to laboratory | 24 | | animal testing, including, but not limited to, in vitro, | 25 | | in silico, and in chemico approaches for identifying skin | 26 | | sensitization hazards.
|
| | | SB1882 Enrolled | - 5 - | LRB103 27260 RLC 53631 b |
|
| 1 | | (b)(1) The Attorney General or a State's Attorney in the | 2 | | county in which a violation of this Act occurred may bring an | 3 | | action in the name of the People of the State to enforce the | 4 | | provisions of this Act.
| 5 | | (2) Whenever the Attorney General, or a State's Attorney | 6 | | in the county in which a violation of this Act occurred, has | 7 | | reason to believe that a testing facility has in engaged in or | 8 | | is engaging in any practice in violation of this Act, and that | 9 | | proceedings would be in the public interest, he or she may | 10 | | bring an action in the name of the People of the State against | 11 | | such testing facility to restrain by preliminary or permanent | 12 | | injunction the use of that practice.
| 13 | | (3) If the court determines that the Attorney General or | 14 | | State's Attorney is the prevailing party in an action filed | 15 | | pursuant to paragraph (1), the official may recover a civil | 16 | | penalty not to exceed $5,000 for each day that each dog or each | 17 | | cat is used in a canine or feline toxicological experiment in | 18 | | violation of this Section. In addition to the civil penalty, | 19 | | the official may also recover court costs and attorney's fees.
| 20 | | (c) The prohibition in subsection (a) does not apply to | 21 | | testing or experimentation conducted for the purpose of | 22 | | developing, manufacturing, or marketing any product intended | 23 | | for beneficial use in dogs or cats.
| 24 | | Section 97. Severability. The provisions of this Act are | 25 | | severable under Section 1.31 of the Statute on Statutes. |
| | | SB1882 Enrolled | - 6 - | LRB103 27260 RLC 53631 b |
|
| 1 | | Section 99. Effective date. This Act takes effect upon | 2 | | becoming law.
|
|